Sheen J, Kennedy-Shaffer L, Levy M, Metcalf C
PLoS Comput Biol. 2025; 21(2):e1012779.
PMID: 39899630
PMC: 11790233.
DOI: 10.1371/journal.pcbi.1012779.
Lund M, Hebert J, Klakk H, Larsen L, Wedderkopp N
Eur J Pediatr. 2025; 184(1):124.
PMID: 39789396
DOI: 10.1007/s00431-024-05959-9.
Berry S, Burton A, Rogers K, Lee C, Berle D
Eur Eat Disord Rev. 2024; 33(2):390-410.
PMID: 39545807
PMC: 11786946.
DOI: 10.1002/erv.3149.
Qian Y, Walters S, Jacques R, Flight L
Stat Methods Med Res. 2024; 33(11-12):1920-1938.
PMID: 39440408
PMC: 11577693.
DOI: 10.1177/09622802241275361.
Libesman S, Li T, Marinovich M, Seidler A, Tagliafico A, Houssami N
Eur Radiol. 2024; 35(3):1478-1489.
PMID: 39363049
PMC: 11836155.
DOI: 10.1007/s00330-024-11085-9.
A qualitative exploration of advantages and disadvantages to using technology in the process of randomised controlled trial recruitment.
Muldowney L, Hynes S, Oglesby M, Dwyer C
HRB Open Res. 2024; 6:56.
PMID: 39211398
PMC: 11358689.
DOI: 10.12688/hrbopenres.13776.2.
The performance of interrupted time series designs with a limited number of time points: Learning losses due to school closures during the COVID-19 pandemic.
van Leeuwen F, Lugtig P, Feskens R
PLoS One. 2024; 19(8):e0301301.
PMID: 39110741
PMC: 11305537.
DOI: 10.1371/journal.pone.0301301.
Assessing uptake of the core outcome set in anxiety disorder clinical trials: a cross-sectional analysis.
Duncan J, Elfar A, Magana K, Jones G, Ward S, Magee T
Qual Life Res. 2024; 33(8):2275-2283.
PMID: 38839683
DOI: 10.1007/s11136-024-03697-x.
Reporting of social determinants of health in randomized controlled trials conducted in the pediatric intensive care unit.
Huang E, Albrecht L, OHearn K, Nicolas N, Armstrong J, Weinberg M
Front Pediatr. 2024; 12:1329648.
PMID: 38361997
PMC: 10867174.
DOI: 10.3389/fped.2024.1329648.
What is the quality of reporting in randomized controlled trials in spinal conditions.
Demetriades A, Tiefenbach J, Park J, Anwar M, Raza S
J Craniovertebr Junction Spine. 2024; 14(4):404-411.
PMID: 38268696
PMC: 10805167.
DOI: 10.4103/jcvjs.jcvjs_121_23.
Rethinking the pros and cons of randomized controlled trials and observational studies in the era of big data and advanced methods: a panel discussion.
Fernainy P, Cohen A, Murray E, Losina E, Lamontagne F, Sourial N
BMC Proc. 2024; 18(Suppl 2):1.
PMID: 38233894
PMC: 10795211.
DOI: 10.1186/s12919-023-00285-8.
Assessment of reporting quality of randomized controlled trials investigating the effects of inulin-type fructans supplementation on cardiovascular disease risk factors: A systematic survey.
Talukdar J, Chu A, Garg A, Chowdhury F, Harnack H, Huang L
PLoS One. 2024; 19(1):e0292184.
PMID: 38166017
PMC: 10760872.
DOI: 10.1371/journal.pone.0292184.
Is There a Movement Towards the Acceptance of Mindfulness in Medical Education? An Audit of Mindfulness Activity in UK Medical Schools.
Harrison L
MedEdPublish (2016). 2023; 8:84.
PMID: 38089300
PMC: 10712599.
DOI: 10.15694/mep.2019.000084.1.
Development of clinical trials for non-small cell lung cancer drugs in China from 2005 to 2023.
Jia W, Yu H, Song L, Wang J, Niu S, Zang G
Front Med (Lausanne). 2023; 10:1239351.
PMID: 38034540
PMC: 10687557.
DOI: 10.3389/fmed.2023.1239351.
The role of quantitative bias analysis for nonrandomized comparisons in health technology assessment: recommendations from an expert workshop.
Leahy T, Durand-Zaleski I, Sampietro-Colom L, Kent S, Zollner Y, Coyle D
Int J Technol Assess Health Care. 2023; 39(1):e68.
PMID: 37981828
PMC: 11579669.
DOI: 10.1017/S0266462323002702.
'Being disabled' as an exclusion criterion for clinical trials: a scoping review.
Camanni G, Ciccone O, Lepri A, Tinarelli C, Bedetti C, Cicuttin S
BMJ Glob Health. 2023; 8(11).
PMID: 37918873
PMC: 10626873.
DOI: 10.1136/bmjgh-2023-013473.
Medication Reviews and Clinical Outcomes in Persons with Dementia: A Scoping Review.
Sharma R, Mahajan N, Fadaleh S, Patel H, Ivo J, Faisal S
Pharmacy (Basel). 2023; 11(5).
PMID: 37888512
PMC: 10609910.
DOI: 10.3390/pharmacy11050168.
The effect of health behavior interventions to manage Type 2 diabetes on the quality of life in low-and middle-income countries: A systematic review and meta-analysis.
Karki A, Vandelanotte C, Khalesi S, Dahal P, Rawal L
PLoS One. 2023; 18(10):e0293028.
PMID: 37844107
PMC: 10578590.
DOI: 10.1371/journal.pone.0293028.
Leveraging the Expertise of the CTSA Program to Increase the Impact and Efficiency of Clinical Trials.
Harris P, Dunsmore S, Atkinson J, Benjamin Jr D, Bernard G, Dean J
JAMA Netw Open. 2023; 6(10):e2336470.
PMID: 37796498
PMC: 10773966.
DOI: 10.1001/jamanetworkopen.2023.36470.
Personalised lifestyle recommendations for type 2 diabetes: Design and simulation of a recommender system on UK Biobank Data.
Cavallo F, Toumazou C
PLOS Digit Health. 2023; 2(8):e0000333.
PMID: 37647301
PMC: 10468058.
DOI: 10.1371/journal.pdig.0000333.